Menu
← Oncology Approval Tracker
FDA DECISION ·
Abiraterone acetate (Yonsa first generic)
abiraterone acetate · Teva Pharmaceuticals USA
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
The first generic of Yonsa 125 mg tablets for metastatic castration-resistant prostate cancer in combination with methylprednisolone.
LAMPGEN ANALYSIS
Why it matters
This generic approval is tied to the Yonsa reference product and its corticosteroid partner.
What research teams should watch
Reconcile the reference formulation, dose and steroid partner before dispensing.
PRIMARY RECORDS